The Swiss pharmaceutical giant operates one of the last penicillin plants in Europe. Losing it would raise new security and sovereignty challenges, says CEO Richard Saynor.
“The simple assumption there was that if we can just increase supply of beef in the U.S., that should lower prices. Unfortunately, the beef industry is much more complex than that.”
From nuclear microreactors on military bases to canned food in British kitchens, two allied governments are bracing for cyberattacks and sabotage that could knock out essential services before a shot is fired.
DC Studios’ R-rated ‘Clayface’ opened at No. 1, Laika’s ‘Wildwood’ debuted in third, and Paramount’s ‘Street Fighter’ lost nearly three-quarters of its audience, while A24’s ‘You Can See Everything’ grew 25% in its second weekend.
As the AI startup prepares to go public, its massive multibillion-dollar cloud commitments threaten to put huge pressure on its margins if customer demand slows down.
Alongside the usual warnings about competition and regulation, Anthropic tells investors its own technology could pose “catastrophic or existential risks to humanity.”
Rich countries are cutting aid at a record pace. The World Bank’s new Philanthropy Hub asks foundations and family offices to route their money through its lending machine, and it’s promising them leverage.